Bambusa Therapeutics

Boston, United States

Bambusa Therapeutics operates as biotechnology company.

$90.0M raised

Feb 2025

Series A

Biotechnology Health Care Life Science Medical

Top Investors

RA Capital ManagementRedmile GroupJanus Henderson InvestorsINCE CapitalInvus

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bambusa Therapeutics

How much funding has Bambusa Therapeutics raised?

Bambusa Therapeutics has raised $90.0M in total funding. The most recent round was Series A. The last funding was announced in February 2025.

Who are Bambusa Therapeutics's investors?

Bambusa Therapeutics's investors include RA Capital Management, Redmile Group, Janus Henderson Investors, INCE Capital, Invus.

Where is Bambusa Therapeutics headquartered?

Bambusa Therapeutics is headquartered in Boston, United States.

What does Bambusa Therapeutics do?

Bambusa Therapeutics operates as biotechnology company.

What stage is Bambusa Therapeutics at?

Bambusa Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 14, 2025.

MLA

"Bambusa Therapeutics — Funding & Investors." VCBacked, February 14, 2025, https://www.vcbacked.co/company/bambusa-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2025). Bambusa Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/bambusa-therapeutics

Wikipedia (cite web)

{{cite web |title=Bambusa Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bambusa-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 14, 2025.